Koninklijke Philips Revenue 2010-2024 | PHG

Koninklijke Philips annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Koninklijke Philips revenue for the quarter ending September 30, 2024 was $4.813B, a 8.27% increase year-over-year.
  • Koninklijke Philips revenue for the twelve months ending September 30, 2024 was $18.965B, a 3.39% decline year-over-year.
  • Koninklijke Philips annual revenue for 2023 was $19.664B, a 4.69% increase from 2022.
  • Koninklijke Philips annual revenue for 2022 was $18.783B, a 7.46% decline from 2021.
  • Koninklijke Philips annual revenue for 2021 was $20.297B, a 9.04% decline from 2020.
Koninklijke Philips Annual Revenue
(Millions of US $)
2023 $19,664
2022 $18,783
2021 $20,297
2020 $22,315
2019 $21,820
2018 $21,401
2017 $20,097
2016 $27,129
2015 $26,921
2014 $28,435
2013 $30,988
2012 $31,880
2011 $31,448
2010 $33,756
2009 $32,339
Koninklijke Philips Quarterly Revenue
(Millions of US $)
2024-09-30 $4,813
2024-06-30 $4,805
2023-06-30 $4,874
2023-03-31 $4,473
2022-06-30 $4,445
2021-06-30 $5,097
2020-06-30 $4,839
2019-06-30 $5,250
2018-06-30 $5,114
2017-06-30 $4,724
2016-12-31 $7,842
2016-09-30 $6,579
2016-06-30 $6,622
2016-03-31 $6,086
2015-12-31 $7,793
2015-09-30 $6,493
2015-06-30 $6,608
2015-03-31 $6,026
2014-12-31 $6,934
2014-09-30 $7,360
2014-06-30 $7,261
2014-03-31 $6,880
2013-12-31 $9,217
2013-09-30 $7,442
2013-06-30 $7,384
2013-03-31 $6,945
2012-12-31 $9,640
2012-09-30 $7,995
2012-06-30 $7,188
2012-03-31 $7,364
2011-12-31 $8,799
2011-09-30 $7,447
2011-06-30 $7,502
2011-03-31 $7,583
2010-12-31 $10,061
2010-09-30 $7,945
2010-06-30 $7,900
2010-03-31 $7,868
2009-12-31 $10,727
2009-09-30 $8,108
2009-06-30 $7,441
2009-03-31 $6,638
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.801B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $222.392B 27.46
Boston Scientific (BSX) United States $154.781B 41.84
Stryker (SYK) United States $150.988B 32.49
EssilorLuxottica (ESLOY) France $128.761B 0.00
Medtronic (MDT) Ireland $116.457B 17.30
Lonza Group Ag (LZAGY) Switzerland $48.724B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
Agilent Technologies (A) United States $42.120B 27.91
GE HealthCare Technologies (GEHC) United States $40.456B 20.98
ResMed (RMD) United States $34.834B 26.83
Terumo (TRUMY) Japan $27.701B 39.39
Zimmer Biomet Holdings (ZBH) United States $20.443B 12.84
Insulet (PODD) United States $20.179B 80.36
Baxter (BAX) United States $15.731B 10.24
Smith & Nephew SNATS (SNN) United Kingdom $11.039B 0.00
Sunny Optical Technology (SNPTF) China $9.976B 0.00
BellRing Brands (BRBR) United States $9.951B 37.15
Bio-Rad Laboratories (BIO) United States $9.670B 32.87
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $6.320B 14.69
Prestige Consumer Healthcare (PBH) United States $4.316B 20.65
ICU Medical (ICUI) United States $3.878B 36.92
Envista Holdings (NVST) United States $3.750B 29.85
Perrigo (PRGO) Ireland $3.407B 10.03
Haemonetics (HAE) United States $3.164B 14.89
GN Store Nord (GNNDY) Denmark $3.123B 21.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.832B 18.23
Neogen (NEOG) United States $2.315B 26.67
LeMaitre Vascular (LMAT) United States $2.245B 54.55
AtriCure (ATRC) United States $1.997B 0.00
Green Thumb Industries (GTBIF) United States $1.513B 26.48
AdaptHealth (AHCO) United States $1.300B 9.29
InMode (INMD) Israel $1.269B 10.61
Maravai LifeSciences Holdings (MRVI) United States $1.250B 0.00
BioLife Solutions (BLFS) United States $1.215B 0.00
Curaleaf Holdings (CURLF) Canada $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.996B 15.27
Evolus (EOLS) United States $0.849B 0.00
CeriBell (CBLL) United States $0.810B 0.00
Owens & Minor (OMI) United States $0.667B 5.21
Capricor Therapeutics (CAPR) United States $0.652B 0.00
VAREX IMAGING (VREX) United States $0.627B 27.14
Valneva SE (VALN) France $0.563B 0.00
Omeros (OMER) United States $0.526B 0.00
SNDL (SNDL) Canada $0.507B 0.00
Surmodics (SRDX) United States $0.487B 0.00
Cresco Labs (CRLBF) United States $0.474B 0.00
Verano Holdings (VRNOF) United States $0.424B 0.00
ZimVie (ZIMV) United States $0.383B 32.26
Canopy Growth (CGC) Canada $0.363B 0.00
Aurora Cannabis (ACB) Canada $0.343B 62.50
Cerus (CERS) United States $0.323B 0.00
Quanterix (QTRX) United States $0.320B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Sanara MedTech (SMTI) United States $0.309B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Biote (BTMD) United States $0.261B 5.73
Zynex (ZYXI) United States $0.252B 52.80
High Tide (HITI) Canada $0.238B 0.00
Sanuwave Health (SNWV) United States $0.232B 3.26
SEMPERIT AG HLD (SEIGY) Austria $0.226B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
TerrAscend (TSNDF) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.203B 15.16
Brainsway (BWAY) Israel $0.200B 106.40
MacroGenics (MGNX) United States $0.174B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.142B 17.83
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.101B 11.44
Exagen (XGN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.085B 0.00
InterCure (INCR) Israel $0.080B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
INLIF (INLF) $0.067B 0.00
Rockwell Medical (RMTI) United States $0.064B 33.00
Cytosorbents (CTSO) United States $0.057B 0.00
Ayr Wellness (AYRWF) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
MariMed (MRMD) United States $0.051B 0.00
United-Guardian (UG) United States $0.051B 14.60
Modular Medical (MODD) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00